securities.stanford.edu/filings-case.html?id=102369

Bristol-Myers Squibb Company has agreed to pay $300 million to the Class Members. The settlement resolves all of the Class Members' claims against the company and the individual defendants. ... Ira Gaines, et al. v. ... One Pennsylvania Plaza, Milberg Weiss Bershad Hynes & Lerach LLP (New York, NY ), NY 10119-1065

openjurist.org/246/f3d/1368/bristol-myers-squibb-company-v-ben-venue-laboratories-inc

Bristol-Myers Squibb Company appeals from the decision of the United ... Mark G . Kris, et al., Phase I Trial of Taxol Given as a 3-Hour Infusion Every ..... For example, Weiss et al., Hypersensitivity Reactions from Taxol, J. Clinical Oncology , Vol.

dockets.justia.com/docket/florida/flndce/3:2019cv00214/102460

Jan 24, 2019 ... Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability case filed on January 24, 2019 in the Florida Northern District ...

www.law360.com/cases/58e6506f2a2edd2f07000001

Parties, docket activity and news coverage of federal case Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., case number 1:17-cv-00379, from  ...

www.patentdocs.org/2019/02/momenta-pharmaceuticals-inc-v-bristol-myers-squibb-co-fed-cir-2019.html

Feb 7, 2019 ... ImmunoGen, Inc.; E. I. du Pont de Nemours & Co. v. ... Momenta Pharmaceuticals , Inc. v, Bristol-Myers Squibb Co. (Fed. ... The case involved a inter partes review ( IPR) brought by Momenta against all claims of U.S. Patent No.

caselaw.findlaw.com/us-federal-circuit/1140879.html

Case opinion for US Federal Circuit BRISTOL MYERS SQUIBB COMPANY v. ... New York, NY, argued for defendants-appellees Ben Venue Laboratories, Inc. et al. ..... For example, Weiss et al., Hypersensitivity Reactions from Taxol, J. Clinical  ...

caselaw.findlaw.com/us-6th-circuit/1878276.html

BRISTOL-MYERS SQUIBB COMPANY; Otsuka America Pharmaceutical, Inc., ... Claims Act (FCA), 31 U.S.C. § 3729 et seq., and several state-law analogues. ... and granted in part and denied in part BMS's motion, dismissing all of the qui tam  ...

www.bms.com/researchers-and-partners/our-r-and-d-team/research-publications.html

All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care ..... Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients ...... Bethesda (MD): Eli Lilly & Company and the National Center for Advancing ...... in patients with impaired renal function: response to Hellfritzsch et al.

www.knobbe.com/news/2019/02/momenta-pharmaceuticals-inc-v-bristol-myers-squibb-company

Feb 7, 2019 ... BRISTOL-MYERS SQUIBB COMPANY. By Jacob R. Rosenbaum ... This case is: MOMENTA PHARMACEUTICALS, INC. v. ... View all articles.